Table 2 Gender gap in the use of qualified outpatient services for NCD care, 2006–2022
From: The gender gap in outpatient care for non-communicable diseases in Mexico between 2006 and 2022
2006–2022 | 2006 | 2011–2012 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|
Incremental risk attributable to NCDs, % [95% CI] | ||||||
Panel A. Non-use of outpatient health services | ||||||
Men | ||||||
Non-NCDs (A) | 42.8 [40.8, 44.8] | 64.8 [62.5, 67.1] | 72.9 [71.1, 74.7] | 29.8 [26.6, 32.9] | 21.3 [18.5, 24.1] | 23.3 [20.4, 26.2] |
NCDs (B) | 27.8 [25.4, 30.2] | 47.6 [44.2, 51.0] | 58.4 [55.3, 61.6] | 18.8 [16.1, 21.6] | 12.5 [10.4, 14.6] | 13.0 [11.0, 15.0] |
Women | ||||||
Non-NCDs (C) | 35.0 [33.4, 36.6] | 57.0 [54.7, 59.3] | 66.0 [64.1, 67.8] | 23.4 [20.8, 25.9] | 16.3 [14.2, 18.4] | 18.0 [15.6, 20.3] |
NCDs (D) | 21.8 [20.0, 23.5] | 39.7 [36.7, 42.7] | 50.4 [47.5, 53.3] | 14.3 [12.3, 16.4] | 9.4 [7.9, 10.9] | 9.7 [8.3, 11.2] |
Gender gapa, % | − 7.4 [− 11.2, − 3.6] | − 12.9 [− 17.8, − 8.0] | − 15.9 [− 21.6, − 10.3] | − 4.9 [− 8.5, − 1.2] | − 3.1 [− 6.4, 0.1] | − 3.3 [− 6.1, − 0.5] |
Panel B. Non segmented use/use according to public health insurance | ||||||
Men | ||||||
Non-NCDs (A) | 26.6 [25.0, 28.3] | 17.6 [16.0, 19.2] | 12.2 [11.0, 13.3] | 27.7 [24.5, 30.8] | 34.0 [30.8, 37.3] | 40.5 [37.1, 43.9] |
NCDs (B) | 47.6 [44.9, 50.3] | 35.6 [32.5, 38.7] | 26.9 [24.2, 29.6] | 48.2 [44.1, 52.4] | 55.3 [51.2, 59.3] | 62.2 [58.6, 65.8] |
Women | ||||||
Non-NCDs (C) | 30.0 [28.6, 31.5] | 21.3 [19.6, 23.1] | 15.2 [13.9, 16.4] | 30.0 [26.9, 33.1] | 35.9 [32.8, 39.1] | 43.1 [39.8, 46.4] |
NCDs (D) | 51.5 [49.0, 53.9] | 40.9 [37.9, 44.0] | 32.0 [29.4, 34.6] | 50.7 [46.7, 54.7] | 57.0 [53.1, 61.0] | 64.3 [60.9, 67.7] |
Gender gapa, % | 10.8 [4.9, 16.7] | 11.8 [6.8, 16.8] | 9.4 [5.6, 13.1] | 7.5 [1.6, 13.3] | 6.2 [− 0.5, 12.9] | 8.5 [1.1, 15.9] |
Panel C. Segmented use—public/use of another public health provider | ||||||
Men | ||||||
Non-NCDs (A) | 1.6 [1.2, 2.0] | 1.8 [1.2, 2.3] | 0.7 [0.5, 0.9] | 1.8 [1.2, 2.5] | 1.9 [1.2, 2.7] | 1.7 [1.1, 2.4] |
NCDs (B) | 2.5 [1.7, 3.4] | 3.2 [2.0, 4.3] | 1.3 [0.8, 1.8] | 2.8 [1.6, 4.0] | 2.7 [1.5, 4.0] | 2.4 [1.3, 3.5] |
Women | ||||||
Non-NCDs (C) | 1.8 [1.4, 2.1] | 2.1 [1.5, 2.7] | 0.8 [0.6, 1.1] | 1.9 [1.3, 2.6] | 1.9 [1.3, 2.6] | 1.8 [1.1, 2.4] |
NCDs (D) | 2.6 [1.9, 3.4] | 3.5 [2.4, 4.7] | 1.5 [1.0, 2.1] | 2.8 [1.7, 4.0] | 2.7 [1.6, 3.8] | 2.3 [1.3, 3.4] |
Gender gapa, % | 13.5 [2.8, 24.1] | 13.9 [5.7, 22.1] | 10.7 [5.1, 16.3] | 9.4 [0.2, 18.5] | 8.2 [− 2.4, 18.8] | 11.9 [− 3.3, 27.0] |
Panel D. Segmented use—private health provider | ||||||
Men | ||||||
Non-NCDs (A) | 29.0 [27.1, 30.8] | 15.9 [14.2, 17.5] | 14.2 [12.9, 15.6] | 40.7 [37.4, 44.1] | 42.8 [39.1, 46.5] | 34.5 [30.8, 38.2] |
NCDs (B) | 22.0 [19.9, 24.1] | 13.6 [11.8, 15.5] | 13.4 [11.6, 15.1] | 30.1 [26.7, 33.6] | 29.5 [25.8, 33.2] | 22.5 [19.4, 25.5] |
Women | ||||||
Non-NCDs (C) | 33.2 [31.7, 34.7] | 19.5 [17.8, 21.3] | 18.0 [16.6, 19.5] | 44.7 [41.5, 47.9] | 45.8 [42.4, 49.3] | 37.2 [33.7, 40.7] |
NCDs (D) | 24.1 [22.0, 26.3] | 15.9 [13.9, 17.9] | 16.1 [14.2, 18.1] | 32.1 [28.6, 35.7] | 30.9 [27.1, 34.6] | 23.6 [20.5, 26.6] |
Gender gapa, % | − 12.0 [− 19.4, − 4.6] | − 24.6 [− 41.9, − 7.3] | − 41.4 [− 87.1, 4.4] | − 7.8 [− 14.0, − 1.5] | − 4.8 [− 9.8, 0.3] | − 4.9 [− 9.1, − 0.7] |